Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sonexa Therapeutics
company
About
Sonexa Therapeutics is a pharmaceutical company that develops drug treatments for Alzheimer's disease and related disorders.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $30M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$30M
Sonexa Therapeutics has raised a total of
$30M
in funding over 2 rounds. Their latest funding was raised on
Jan 31, 2008 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 31, 2008 | Series A | $30M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Sonexa Therapeutics has made 1 investments. Their most recent investment was on
Jul 30, 2009, when Well.ca raised $1.10M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 30, 2009
Well.ca
|
Series Unknown | $1.10M | Beauty | — |
Investors
Number of Lead Investors
Number of Investors
—
1
Sonexa Therapeutics is funded by 1 investors.
AgeChem Venture Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
AgeChem Venture Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
